Cure of CLL
- 總結
- Derivatives of para-nitric oxide-donating acetylsalicylic acid provide novel compounds for the treatment of CLL.
- 技術優勢
- Compound claims towards novel derivatives of para-NO-ASA: High selectivity, high activity, tested on different CLL cell populations, proven in a xenograft model of CLL
Development team comprising chemists and clinicians
Compounds may be suitable for the treatment of other neoplasias
- 技術應用
- effective and selective medicament for the treatment of neoplastic diseases or proliferative disorders
- 詳細技術說明
- The present invention provides compounds acting as an effective and selective medicament for the treatment of neoplastic diseases or proliferative disorders, in particular compounds which induce selectively apoptosis of degenerated cells providing reduced side effects in living organisms
- 合作類型
- Licensing
- 申請日期
- 24/09/2014 00:00:00
- 申請號碼
- EP20140771921 20140924
- 分類
- - international:
A61K31/621; A61K31/695; A61P35/00; A61P35/02; C07C203/04; C07C247/10; C07C309/76; C07C69/76; C07F7/08
- cooperative:
A61K31/215; A61K31/235; A61K31/24; A61K31/621; C07C203/04; C07C247/10; C07C309/76; C07C69/75; C07C69/76; C07C69/78; C07C69/86; C07F7/081; C07F7/1804; C07C2601/14
- 其他
- Patent application
- ID號碼
- 4045
- 國家/地區
- 德國
欲了解更多信息，請點擊 這裡
